IONS - CIK 0000874015
IONIS PHARMACEUTICALS INC (IONS) reported net income of -$381.39M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$381.39M | +16.0% |
| FY 2024 | -$453.90M | -23.9% |
| FY 2023 | -$366.29M | -35.8% |
| FY 2022 | -$269.72M | -843.2% |
| FY 2021 | -$28.60M | +93.6% |
| FY 2020 | -$444.26M | -259.7% |
| FY 2019 | $278.14M | +1.6% |
| FY 2018 | $273.74M | +79015.9% |
| FY 2017 |
IONIS PHARMACEUTICALS INC (IONS) reported net income of -$381.39M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2009 and fiscal 2025, IONIS PHARMACEUTICALS INC's net income declined from $155.07M to -$381.39M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $346.00K |
| +100.6% |
| FY 2016 | -$60.40M | +31.6% |
| FY 2015 | -$88.28M | -126.4% |
| FY 2014 | -$38.98M | +35.7% |
| FY 2013 | -$60.64M | +1.0% |
| FY 2010 | -$61.25M | -139.5% |
| FY 2009 | $155.07M | - |